Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00430612 · ClinicalTrials.gov registry record

The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)

A clinical trial of Myocardial Infarction, sponsored by Northwestern University.

Completed
Registry status
7,057
Enrollment target
20
Study locations

NCT00430612 is a study of Myocardial Infarction that has completed, run by Northwestern University. The registered enrollment target is 7,057 participants, above the 4,571-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (54% higher). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00430612, a study of Myocardial Infarction, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
7,057 participants
Enrollment target
20
Study locations

Study Summary

The purpose of the PACE-MI (OBTAIN) registry is: * Analyze beta-blocker dose response effect on outcome over two years * Explore gender and minority differences in beta-blocker utilization and outcomes. In patients with Myocardial Infarction (MI) discharged from the hospital, beta-blocker dose will be predictive of survival. Exploratory analyses: Gender and racial effects-gender and race are, similarly, hypothesized to be predictive of post-MI survival. The existence of interactions between gender and beta-blocker effect as well as race and beta-blocker effect will also be evaluated.

Conditions Studied

Myocardial Infarction

Study Locations (20)

New York

  • Winthrop University Hospital - Bethpage
  • Maimonides Medical Center - Brooklyn
  • Strong Memorial Hospital (University of Rochester School of Medicine) - Rochester

California

  • MemorialCare Heart and Vascular Institute - Long Beach Memorial Medical Center - Long Beach
  • West Los Angeles VA Medical Center - Los Angeles

Florida

  • Baptist Cardiac and Vascular Institute - Miami
  • Orlando Regional Medical Center - Orlando

Texas

  • Amarillo Heart Clinic Research Institute, Inc. - Amarillo
  • Austin Heart PLLC - Austin

Arkansas

  • Little Rock Cardiology Clinic - Little Rock

Connecticut

  • Bridgeport Hospital - Bridgeport

Illinois

  • Northwestern Memorial Hospital - Chicago

Indiana

  • Clarian Health/Methodist Research Institute - Indianapolis

Trial Details

FieldValue
Enrollment Target 7,057 participants
Start Date 2009-05
Est. Completion 2015-10

Sponsor

Northwestern University

1,209 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00430612

The ClinicalTrials.gov registry entry for NCT00430612 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,057 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,571-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (54% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.

NCT00430612 reports 20 study locations spanning 15 distinct geographic areas - top geographies include New York, California, Florida.

Frequently Asked Questions

What is clinical trial NCT00430612 about?

NCT00430612 is a clinical study titled "The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)". The purpose of the PACE-MI (OBTAIN) registry is: * Analyze beta-blocker dose response effect on outcome over two years * Explore gender and minority differences in beta-blocker utilization and outcomes. In patients with Myocardial Infarction (MI) discharged from the hospital, beta-blocker dose wil...

What is the current status of trial NCT00430612?

This trial is currently completed. The enrollment target is 7,057 participants. The study started on 2009-05. Estimated completion is 2015-10.

What conditions does trial NCT00430612 study?

This clinical trial studies the following conditions: Myocardial Infarction.

Who is sponsoring clinical trial NCT00430612?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00430612 being conducted?

This trial has 20 study locations across Arkansas, California, Connecticut, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myocardial Infarction

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.